These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 35855062)

  • 21. Age-Dependent Risks of COVID-19 Putatively Caused by Variant Alpha in Japan.
    Kayano T; Hayashi K; Kobayashi T; Nishiura H
    Front Public Health; 2022; 10():837970. PubMed ID: 35757644
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Simultaneous Screening of SARS-CoV-2 Omicron and Delta Variants Using High-Resolution Melting Analysis.
    Aoki A; Mori Y; Okamoto Y; Jinno H
    Biol Pharm Bull; 2022 Apr; 45(4):394-396. PubMed ID: 35067489
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Epidemiological feature, viral shedding, and antibody seroconversion among asymptomatic SARS-CoV-2 carriers and symptomatic/presymptomatic COVID-19 patients.
    Chen Y; Li P; Ding Y; Liu M; Liu L; Yi B; Wu T; Dong H; Lao X; Ding K; Wang H; Zhang D; Tan X; Wang Z; Xu G; Cao G
    J Infect Public Health; 2021 Jul; 14(7):845-851. PubMed ID: 34118734
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Household Transmission of Severe Acute Respiratory Syndrome Coronavirus-2 in the United States.
    Lewis NM; Chu VT; Ye D; Conners EE; Gharpure R; Laws RL; Reses HE; Freeman BD; Fajans M; Rabold EM; Dawson P; Buono S; Yin S; Owusu D; Wadhwa A; Pomeroy M; Yousaf A; Pevzner E; Njuguna H; Battey KA; Tran CH; Fields VL; Salvatore P; O'Hegarty M; Vuong J; Chancey R; Gregory C; Banks M; Rispens JR; Dietrich E; Marcenac P; Matanock AM; Duca L; Binder A; Fox G; Lester S; Mills L; Gerber SI; Watson J; Schumacher A; Pawloski L; Thornburg NJ; Hall AJ; Kiphibane T; Willardson S; Christensen K; Page L; Bhattacharyya S; Dasu T; Christiansen A; Pray IW; Westergaard RP; Dunn AC; Tate JE; Nabity SA; Kirking HL
    Clin Infect Dis; 2021 Oct; 73(7):1805-1813. PubMed ID: 33185244
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Duration of Infectious Virus Shedding by SARS-CoV-2 Omicron Variant-Infected Vaccinees.
    Takahashi K; Ishikane M; Ujiie M; Iwamoto N; Okumura N; Sato T; Nagashima M; Moriya A; Suzuki M; Hojo M; Kanno T; Saito S; Miyamoto S; Ainai A; Tobiume M; Arashiro T; Fujimoto T; Saito T; Yamato M; Suzuki T; Ohmagari N
    Emerg Infect Dis; 2022 May; 28(5):998-1001. PubMed ID: 35290176
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Transmission dynamics and epidemiological characteristics of SARS-CoV-2 Delta variant infections in Guangdong, China, May to June 2021.
    Kang M; Xin H; Yuan J; Ali ST; Liang Z; Zhang J; Hu T; Lau EH; Zhang Y; Zhang M; Cowling BJ; Li Y; Wu P
    Euro Surveill; 2022 Mar; 27(10):. PubMed ID: 35272744
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evidence Supporting Transmission of Severe Acute Respiratory Syndrome Coronavirus 2 While Presymptomatic or Asymptomatic.
    Furukawa NW; Brooks JT; Sobel J
    Emerg Infect Dis; 2020 Jul; 26(7):. PubMed ID: 32364890
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Transmission Potential of Asymptomatic and Paucisymptomatic Severe Acute Respiratory Syndrome Coronavirus 2 Infections: A 3-Family Cluster Study in China.
    Jiang XL; Zhang XL; Zhao XN; Li CB; Lei J; Kou ZQ; Sun WK; Hang Y; Gao F; Ji SX; Lin CF; Pang B; Yao MX; Anderson BD; Wang GL; Yao L; Duan LJ; Kang DM; Ma MJ
    J Infect Dis; 2020 Jun; 221(12):1948-1952. PubMed ID: 32319519
    [TBL] [Abstract][Full Text] [Related]  

  • 29. SARS-CoV-2 Seroprevalence before Delta Variant Surge, Chattogram, Bangladesh, March-June 2021.
    Bhuiyan TR; Hulse JD; Hegde ST; Akhtar M; Islam T; Khan ZH; Khan II; Ahmed S; Rashid M; Rashid R; Gurley ES; Shirin T; Khan AI; Azman AS; Qadri F
    Emerg Infect Dis; 2022 Feb; 28(2):429-431. PubMed ID: 35076007
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Implications of Shortened Quarantine Among Household Contacts of Index Patients with Confirmed SARS-CoV-2 Infection - Tennessee and Wisconsin, April-September 2020.
    Rolfes MA; Grijalva CG; Zhu Y; McLean HQ; Hanson KE; Belongia EA; Halasa NB; Kim A; Meece J; Reed C; Talbot HK; Fry AM
    MMWR Morb Mortal Wkly Rep; 2021 Jan; 69(5152):1633-1637. PubMed ID: 33382676
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Kinetics of Neutralizing Antibody Responses Against SARS-CoV-2 Delta Variant in Patients Infected at the Beginning of the Pandemic.
    Choe PG; Kim Y; Chang E; Kang CK; Kim NJ; Cho NH; Park WB; Oh MD
    J Korean Med Sci; 2022 Feb; 37(8):e67. PubMed ID: 35226425
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Vaccine effectiveness against SARS-CoV-2 transmission to household contacts during dominance of Delta variant (B.1.617.2), the Netherlands, August to September 2021.
    de Gier B; Andeweg S; Backer JA; ; Hahné SJ; van den Hof S; de Melker HE; Knol MJ;
    Euro Surveill; 2021 Nov; 26(44):. PubMed ID: 34738514
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Household transmission of SARS-CoV-2 from unvaccinated asymptomatic and symptomatic household members with confirmed SARS-CoV-2 infection: an antibody-surveillance study.
    Bhatt M; Plint AC; Tang K; Malley R; Huy AP; McGahern C; Dawson J; Pelchat M; Dawson L; Varshney T; Arnold C; Galipeau Y; Austin M; Thampi N; Alnaji F; Langlois MA; Zemek RL
    CMAJ Open; 2022; 10(2):E357-E366. PubMed ID: 35414597
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Acquisition of the L452R Mutation in the ACE2-Binding Interface of Spike Protein Triggers Recent Massive Expansion of SARS-CoV-2 Variants.
    Tchesnokova V; Kulasekara H; Larson L; Bowers V; Rechkina E; Kisiela D; Sledneva Y; Choudhury D; Maslova I; Deng K; Kutumbaka K; Geng H; Fowler C; Greene D; Ralston J; Samadpour M; Sokurenko E
    J Clin Microbiol; 2021 Oct; 59(11):e0092121. PubMed ID: 34379531
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Asymptomatic SARS-CoV-2 Infection in Household Contacts of a Healthcare Provider, Wuhan, China.
    Luo Y; Trevathan E; Qian Z; Li Y; Li J; Xiao W; Tu N; Zeng Z; Mo P; Xiong Y; Ye G
    Emerg Infect Dis; 2020 Aug; 26(8):1930-1933. PubMed ID: 32330112
    [TBL] [Abstract][Full Text] [Related]  

  • 36. mRNA-Based Vaccine BNT162b2 Might Reduce Severe Acute Respiratory Syndrome Coronavirus 2 B.1.1.7 Variant Transmission in Japanese Population.
    Matsunaga T; Higashidate Y; Inazawa N; Ando S; Takahashi M
    Cureus; 2021 Oct; 13(10):e19140. PubMed ID: 34737915
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Expansion of L452R-Positive SARS-CoV-2 Omicron Variant, Northern Lombardy, Italy.
    Novazzi F; Baj A; Genoni A; Focosi D; Maggi F
    Emerg Infect Dis; 2022 Jun; 28(6):1301-1302. PubMed ID: 35416767
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Soaring Asymptomatic Infected Individuals Bring About Barriers and Difficulties for Interruption of COVID-19 Prevalence in China.
    Chen M; Ai L; Huang D; Chen J; Feng T; Mei S; Huang Y; Peng B; Zhang S; Zhang R; Zhou X
    Vector Borne Zoonotic Dis; 2021 Oct; 21(10):777-784. PubMed ID: 34375121
    [No Abstract]   [Full Text] [Related]  

  • 39. Household Exposure to Severe Acute Respiratory Syndrome Coronavirus 2 and Association With Coronavirus Disease 2019 Severity: A Danish Nationwide Cohort Study.
    Broccia M; de Knegt VE; Mills EHA; Møller AL; Gnesin F; Fischer TK; Zylyftari N; Blomberg SN; Andersen MP; Schou M; Fosbøl E; Kragholm K; Christensen HC; Polcwiartek LB; Phelps M; Køber L; Torp-Pedersen C
    Clin Infect Dis; 2022 Jan; 74(1):1-7. PubMed ID: 33893489
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Increased COVID-19 Severity among Pregnant Patients Infected with SARS-CoV-2 Delta Variant, France.
    Zayet S; Gendrin V; Gay C; Selles P; Klopfenstein T
    Emerg Infect Dis; 2022 May; 28(5):1048-1050. PubMed ID: 35180376
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.